The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Potency of CD8+ T-cell mediated antitumor immunity from intratumoral immunotherapy with STING agonist, ADU-S100, in an esophageal adenocarcinoma model.
 
Laila Babar
No Relationships to Disclose
 
Ali Hussainy Zaidi
No Relationships to Disclose
 
Ronan Joseph Kelly
Consulting or Advisory Role - Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Cardinal Health; Cardinal Health; Cardinal Health; Cardinal Health; Clovis Oncology; Clovis Oncology; Clovis Oncology; Clovis Oncology; EMD Serono; EMD Serono; EMD Serono; EMD Serono; Gritstone Bio; Gritstone Bio; Gritstone Bio; Gritstone Bio; Lilly; Lilly; Lilly; Lilly; Medscape; Medscape; Medscape; Medscape; Merck; Merck; Merck; Merck; Novartis; Novartis; Novartis; Novartis; OncoMed; OncoMed; OncoMed; OncoMed
Research Funding - AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst)
 
Ashten N. Omstead
No Relationships to Disclose
 
Ping Zheng
No Relationships to Disclose
 
Juliann E. Kosovec
No Relationships to Disclose
 
Shahin Ayazi
No Relationships to Disclose
 
Gene Grant Finley
Speakers' Bureau - Astellas Medivation; Astellas Medivation; Astellas Medivation; Astellas Medivation; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Merck; Merck; Merck; Merck
Research Funding - AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); BeyondSpring Pharmaceuticals (Inst); BeyondSpring Pharmaceuticals (Inst); BeyondSpring Pharmaceuticals (Inst); BeyondSpring Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Genentech/Roche; Genentech/Roche; Genentech/Roche; Genentech/Roche
 
Blair Anderson Jobe
No Relationships to Disclose
 
Ajay Goel
No Relationships to Disclose
 
Anastasia Gorbunova
No Relationships to Disclose
 
Madison Salvitti
No Relationships to Disclose